ð¥ å
§ç§å°ç§èåç
Mechanistic Deep Dive
Premature Trypsinogen Activation
- Trypsin activates other proenzymes
- Self-perpetuating autodigestion
- Severity related to extent
Hypertriglyceridemia-Induced AP
- TG > 1000-2000 mg/dL
- Fatty acid lipotoxicity
- More severe course
- Treat with insulin infusion ± apheresis
Smoking + Pancreatitis
- Independent risk factor
- Synergistic with alcohol
- Important counseling target
Recent Trials & Updates
PAMPHLET (2022)
- Aggressive LR vs NS for AP
- LR slightly better
WATERFALL (2022)
- Aggressive vs moderate fluid resuscitation
- Moderate sufficient; aggressive â volume overload
PANTER (2010)
- Step-up vs primary surgery for necrotizing pancreatitis
- Step-up better outcomes
TPIAT (Total Pancreatectomy + Islet Auto-Transplant)
- For severe refractory CP pain
- â Pain + â QoL
- Maintain endocrine function (partial)
High-Yield Specialist Points
Post-ERCP Pancreatitis Prevention
- Rectal NSAIDs (indomethacin 100 mg) â preventive
- Hydration
Drug-Induced AP Workup
- High suspicion for new drug starts
- Time relationship
- Common: didanosine, pentamidine, valproate, azathioprine, mesalamine, statins, GLP-1 (controversial)
Necrotizing Pancreatitis Distinction
- Infected vs sterile necrosis
- Procalcitonin marker
- Gas on imaging = infected
- Antibiotics + drainage if infected
Walled-Off Necrosis Drainage
- Endoscopic transmural with LAMS (lumen-apposing metal stents) â preferred
- Multiple endoscopic necrosectomies often needed
- Outpatient procedures
Chronic Pancreatitis Pain Management
- Multimodal approach
- Avoid chronic opioids if possible
- Endoscopic interventions for ductal stenosis
- Celiac plexus block
- Surgery (Beger, Frey, Whipple) for refractory
TPIAT Indications
- Severe refractory pain
- Recurrent acute pancreatitis
- â Risk pancreatic cancer (hereditary)
- Centers of excellence
Pancreatic Cancer Screening
- Hereditary pancreatitis
- BRCA1/2 mutation carriers
- Lynch syndrome
- Family clusters
- Annual MRI / EUS at specialized centers
Pediatric Pancreatitis
- Often hereditary or metabolic
- Different prevalence of etiologies
- Specialty referral
Pancreatic Cysts
- IPMN (intraductal papillary mucinous neoplasm)
- Mucinous cystic neoplasm
- Serous cystadenoma
- Pseudocyst
- MRI/MRCP for characterization
- EUS-FNA selected
- Surveillance vs surgery
Diabetic Type 3c
- Pancreatic in origin
- Brittle (loss of glucagon counter-regulation)
- Insulin + carbohydrate management
- Frequent monitoring
Pearls
- AP diagnosis 2 of 3: pain + lipase + imaging
- Etiology âI GET SMASHEDâ mnemonic
- Atlanta 2012 severity: mild, moderate, severe
- Treatment: aggressive IV LR + analgesia + early oral feeding + ERCP if obstructive
- Antibiotics only for infected necrosis
- Step-up approach: percutaneous â endoscopic â surgery
- CP: alcohol + smoking; PERT + insulin
- AIP: steroid-responsive (Type 1 IgG4 + Type 2 idiopathic)
- TPIAT: refractory CP pain